ArticleCureus2026
Refractory Dysphagia and Severe Iron Deficiency Anemia in a Woman With Plummer-Vinson Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plummer-Vinson syndrome (PVS) is a rare clinical entity defined by the triad of iron deficiency anemia, dysphagia, and an upper esophageal web. Its prevalence has declined worldwide in parallel with improvements in nutrition, and the condition is therefore encountered infrequently in contemporary practice. Because PVS carries an increased risk of squamous cell carcinoma of the hypopharynx and upper esophagus, timely recognition and long-term surveillance are important. We report a 47-year-old woman who presented with a four-month history of progressive dysphagia that had not responded to a one-month course of proton pump inhibitor (PPI) therapy prescribed at another center. Laboratory evaluation revealed severe microcytic hypochromic anemia with a hemoglobin level of 7 g/dL (reference range: 12.0-16.0 g/dL), a mean corpuscular volume (MCV) of 52 fL (reference range: 80-100 fL), and a ferritin level of 3 ng/mL (reference range: 15-150 ng/mL). Intravenous ferric carboxymaltose was administered, and upper gastrointestinal endoscopy demonstrated a web at the esophageal inlet, which was dilated during the same session. By the third month, the hemoglobin level had risen to 13 g/dL, with complete resolution of dysphagia. This case illustrates that progressive dysphagia unresponsive to antisecretory therapy is an alarm symptom warranting prompt endoscopic evaluation, and that a simple complete blood count may provide the decisive diagnostic clue in such patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.